Male

Dr. Michael A. Coe, M.Ed, D.Div.'s newly released "He Looks Like Me: An evidence based guide for teachers mentoring African American Boys" is an informative resource

Retrieved on: 
Monday, December 5, 2022
Barnes, Master of Education, Male, All American Boys, Mercer County Community College, Certificate, Supervisor, Apple, Christianity, Cairn University, Mercer County, Amazon (company), The College of New Jersey, Research, College, Gratz College, Education, Mentorship, ITunes, Applied science, Associate, Reading, Principal, Hope, Student, Tutoring, Science, Noble

MEADVILLE, Pa., Dec. 5, 2022 /PRNewswire-PRWeb/ -- "He Looks Like Me: An evidence based guide for teachers mentoring African American Boys": a helpful study of the positive effects of partnering young men of color with positive role models with similar backgrounds. "He Looks Like Me: An evidence based guide for teachers mentoring African American Boys" is the creation of published author Dr. Michael A. Coe, M.Ed, D.Div., a dedicated father of two and a special education teacher for twenty-one years. Dr. Coe dedicated his life to bringing change to African American males in the inner-city community. He holds an Associate of Applied Science in general business from Mercer County Community College, West Windsor, New Jersey; a Bachelor of Science in biblical studies from Cairn University in Langhorne, Pennsylvania; a Master of Education from Gratz College Melrose Park, Pennsylvania; a post master's degree in school administration from The College of New Jersey, Ewing, New Jersey; and a Doctor of Divinity from Isaiah University, Daytona Beach, Florida. He also holds a New Jersey Teacher of the Handicapped Certificate K–12, a Supervisor's Certificate, and a Principal's Certificate.

Key Points: 
  • "He Looks Like Me: An evidence based guide for teachers mentoring African American Boys" from Christian Faith Publishing author Dr. Michael A. Coe, M.Ed, D.Div.
  • MEADVILLE, Pa., Dec. 5, 2022 /PRNewswire-PRWeb/ -- "He Looks Like Me: An evidence based guide for teachers mentoring African American Boys": a helpful study of the positive effects of partnering young men of color with positive role models with similar backgrounds.
  • "He Looks Like Me: An evidence based guide for teachers mentoring African American Boys" is the creation of published author Dr. Michael A. Coe, M.Ed, D.Div., a dedicated father of two and a special education teacher for twenty-one years.
  • For additional information or inquiries about "He Looks Like Me: An evidence based guide for teachers mentoring African American Boys," contact the Christian Faith Publishing media department at 866-554-0919.

BrainFit app launches on Women's Brain Health Day

Retrieved on: 
Friday, December 2, 2022
Friends, CTV, Woman, TELUS, CN Tower, Male, Alzheimer's disease, Female, Sleep, Motivation, Public Health Agency of Canada, Government of Canada, Calgary Tower, Health Canada, Anxiety, Research, Exercise, Bank of Montreal, Depression, York University, BMO, Social media, Partnership, Home Instead Senior Care UK, RBC, Habit, Risk, Government, Dementia, Public Health Agency, Montreal Tower, The Tower, Mobile phone, Pharmaceutical industry

TORONTO, Dec. 2, 2022 /CNW/ - On the fourth annual Women's Brain Health Day, Women's Brain Health Initiative (WBHI) announces the launch of BrainFit, a free habit tracking mobile app created to help users optimize their brain health.

Key Points: 
  • TORONTO, Dec. 2, 2022 /CNW/ - On the fourth annual Women's Brain Health Day, Women's Brain Health Initiative (WBHI) announces the launch of BrainFit, a free habit tracking mobile app created to help users optimize their brain health.
  • "Women's Brain Health Day is the ideal time to announce the launch of BrainFit," said WBHI President and CEO Lynn Posluns.
  • "BrainFit is our newest initiative to educate the public on the best ways to protect their brain health.
  • Women's Brain Health Day was officially recognized by the Government of Canada in 2019 and shines a spotlight on the fact that many serious brain health conditions, such as Alzheimer's disease, anxiety, and depression, occur more frequently in women than in men.

PDFNJ’s Knock Out Opioid Abuse Initiative Places the Focus on New Jersey Student-Athletes

Retrieved on: 
Thursday, December 1, 2022
Athlete, Adolescence, Injury, CDC, NJSIAA, Communication, Organization, Rutgers University, Risk, Pain, Student, Advertising, New Jersey State Interscholastic Athletic Association, Opioid, Government, NFL, Parent, Harrison, Male, Health, Sport, Partnership, Illegal drug trade, Pharmaceutical industry

Sports-related injuries are something that many student-athletes will face, said Angelo Valente, Executive Director of the Partnership for a Drug-Free New Jersey.

Key Points: 
  • Sports-related injuries are something that many student-athletes will face, said Angelo Valente, Executive Director of the Partnership for a Drug-Free New Jersey.
  • To reach these student-athletes, PDFNJ and Horizon Blue Cross Blue Shield of New Jersey and the New Jersey State Interscholastic Athletic Association (NJSIAA) have been working together to raise awareness of the dangers of prescription opioids by bringing their Knock Out Opioid Abuse initiative to high schools throughout New Jersey.
  • The program is headlined by former Rutgers and NFL quarterback Ray Lucas, who has spoken openly about his past struggles with opioid addiction.
  • Lucas, a Harrison native, starred at Rutgers University in the 1990s before enjoying an eight-year career in the NFL.

JOIN VICTIMS & ADVOCATES FOR JUSTICE IN DEADLY CAMP LEJEUNE WATER CONTAMINATION

Retrieved on: 
Thursday, December 1, 2022
Department of Defence, Blair Brandt, Erin Brockovich, History, Nature, Drinking water, The Truth Seekers, Government, Joint Base Pearl Harbor–Hickam, Pacific Gas and Electric Company, Veteran, Groundwater, Birth, City, Marines, Male, Water, Electricity, GiFT, Breast cancer, Leukemia, Defense Department Advisory Committee on Women in the Services, Life insurance, Paul A. Partain

This year, the government finally acknowledged the harm caused decades ago by the pollution at Camp Lejeune.

Key Points: 
  • This year, the government finally acknowledged the harm caused decades ago by the pollution at Camp Lejeune.
  • Erin Brockovich has joined Ensminger and Partain in seeking justice for Camp Lejeune victims.
  • Together, they pushed for the successful passage of a bill in 2012 to provide healthcare for Camp Lejeune victims.
  • Partain and Ensminger were both featured in an award-winning documentary about the Camp Lejeune contamination, Semper Fi: Always Faithful.

Global Lingerie Market Report 2022: A $112.96 Billion Market by 2027 - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Fashion, Retail, Consumer, Department Stores, Women, Specialty, Men, COVID-19, Social media, Urbanization, Male, Retail, Potash, Growth

The "Lingerie Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lingerie Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global lingerie market reached a value of US$ 72.66 billion in 2021.
  • The increasing inclination of consumers toward trendy intimate wear and sportswear is one of the key factors driving the market growth.
  • What is the structure of the global lingerie market and who are the key players?

Laryngoscope Global Market Report 2022

Retrieved on: 
Thursday, December 1, 2022
Growth, Roper Technologies, Tongue, Injury, Johns Hopkins University, Head, Organization, Medtronic, Infection, Prevalence, Laryngeal cancer, Risk, Hospital, Female, Cancer, Laryngoscopy, Health, Chronic Respiratory Disease, Pharynx, Patient, KARL, Death, Larynx, Male, Surgeon, Olympus, Vocal cords, Workload, Safety, ETT, Medical imaging

DUBLIN, Dec. 1, 2022 /PRNewswire/ --The "Laryngoscope Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 1, 2022 /PRNewswire/ --The "Laryngoscope Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • This report provides the strategists, marketers and senior management with the critical information they need to assess the global laryngoscope market.
  • The report gives a guide to the laryngoscope market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
  • The main types of the laryngoscope market are indirect laryngoscope and direct laryngoscope.

Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research

Retrieved on: 
Thursday, December 1, 2022
Other Health, Research, General Health, Oncology, Biometrics, Genetics, Clinical Trials, Science, Cardiology, Biotechnology, Other Science, Health, Lucid, Cell, Gene, Risk, Security (finance), LDT, NGS, Methylation, Incidence, Conference, Cyclin A1, Patient, Therapy, Laboratory developed test, VIM, Obesity, FDA, COVID-19, American College of Gastroenterology, EAC, Diagnosis, American College, DNA, Physician, Annual report, Anesthesia, Male, Research, Interception, Esophageal, Science Translational Medicine, Esophageal cancer, GERD, CCNA1, American Gastroenterological Association, Death, CE marking, Medical imaging, Pharmaceutical industry, Part Two, Cancer, Vimentin

Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), today announced that Suman M. Verma, M.D., Ph.D., Lucids Chief Scientific Officer, presented real-world data on its EsoCheck Cell Collection Device (EsoCheck) at the American Association for Cancer Researchs (AACR) Special Conference: Precision Prevention, Early Detection, and Interception of Cancer.

Key Points: 
  • Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), today announced that Suman M. Verma, M.D., Ph.D., Lucids Chief Scientific Officer, presented real-world data on its EsoCheck Cell Collection Device (EsoCheck) at the American Association for Cancer Researchs (AACR) Special Conference: Precision Prevention, Early Detection, and Interception of Cancer.
  • Millions of patients with GERD are at risk of developing esophageal precancer and a highly lethal form of esophageal cancer (EAC).
  • Over 80% of EAC patients die within five years of diagnosis, making it the second most lethal cancer in the U.S.
  • Lucid Diagnostics Inc. (Nasdaq: LUCD) is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM).

New Report: Identity fraud doubled in crypto and banking in 2022

Retrieved on: 
Thursday, December 1, 2022
Technology, Mobile, Wireless, Online Privacy, Finance, Professional Services, Payments, Digital Cash Management, Digital Assets, Software, Data Analytics, Internet, Fintech, Cryptocurrency, Data Management, Security, IOS, Statistics, Growth, Cyprus Securities and Exchange Commission, AML, KYB, FINMA, AI, Crime, Multimedia, IDS, Transport, DiDi, Lead, On the Ground News Reports, Chargeback fraud, Deepfake, ID, KYT, FCA, Male, Research, Android, Federal Financial Supervisory Authority, MAS, Fraud, Chart, KYC, FATF, Cryptocurrency, Online shopping, Security printing, Medical device

View the full release here: https://www.businesswire.com/news/home/20221201005132/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221201005132/en/
    New Report: Identity fraud doubled in crypto and banking in 2022 (Graphic: Business Wire)
    Seven key findings from Sumsubs Identity Fraud Report:
    In 2022, over half of all fraud cases happened in five countries: Bangladesh (22%), Pakistan (15.2%), Vietnam (8.1%), Nigeria (5.4%) and the USA (5.1%).
  • The Sumsub report also highlights an approximately twofold increase in fraud targeting the crypto industryfrom 0.7% of all fraud cases to 1.5%.
  • Payment fraud grew 40% from 2021 to 2022, significantly increasing the share of this type of fraud worldwide.
  • Sumsubs annual identity fraud report for 2022 is available for download at this link: https://sumsub.com/fraud-report-2022/
    Sumsub research was performed between 2021 and 2022 with a focus on global fraud trends.

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Files EZ-G Patent Application to Include Double Faceted Condom

Retrieved on: 
Thursday, December 1, 2022
COVID-19, Condom, Software, Marketing, Pleasure, BCAN, Pharmacy, BETA, Lubricant, BYND, Ministry, Female, Cannabis, Patent, SEDAR, Male, CBD, CRM, CSE, Human, Acquisition, Birth control, Drug

ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 01, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (BYND Cannasoft or the Company) announced today the filing of a patent application for its EZ-G device to include an innovative double-faceted condom design.

Key Points: 
  • ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 01, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (BYND Cannasoft or the Company) announced today the filing of a patent application for its EZ-G device to include an innovative double-faceted condom design.
  • According to the patent application, the condom will have a double pocket that will contain a lubricant that is released evenly when used.
  • Yftah Ben Yaackov, CEO and Director of BYND Cannasoft, said, The filing of our patent application for the EZ-G device to include a double-faceted condom design could create additional value for BYND Cannasoft.
  • Should we be successful with the examination of our patent application, the global condom market is fragmented, but growing significantly.

Hamilton Thorne Announces the Acquisition of Microptic, S.L.

Retrieved on: 
Thursday, December 1, 2022
Software, Growth, Fertility clinic, Adjustment, CFO, D, Fertility, EBITDA, TSX, AI, Hand, Machine learning, Quarter, Artificial intelligence, TSX Venture Exchange, Analysis, CASA, Middlesex Savings Bank, European, SEDAR, Reproductive technology, Male, Financial statement, Senior debt, ART, Research, Transaction, HTL, Depreciation, Assisted reproductive technology, Acquisition, Risk management, Security (finance), Bank, Virtual assistant

BEVERLY, Mass. and TORONTO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ("ART") research, and cell biology markets, today announced that it has closed the acquisition (the "Transaction") of Microptic, S.L. ("Microptic") effective as of November 30, 2022.

Key Points: 
  • The Transaction expands Hamilton Thorne's product offerings and provides the Company with profitable operations in the well-established European ART market.
  • Key Benefits of the Transaction:
    "We are excited to welcome our new partners from Microptic to the Hamilton Thorne family.
  • This acquisition enhances our product offerings in AI enabled CASA software, image analysis systems, consumables, and related products.
  • Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, Tek-Event brands, and Microptic, through its growing sales force and distributors worldwide.